Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 1, 2008, Pages 54.e1-54.e4

  De Boer, Inge P ^a   Zeestraten, Eliane C M ^a   Lopriore, Enrico ^a   van Kamp, Inge L ^a   Kanhai, Humphrey H H ^a   Walther, Frans J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

anemia; hyperbilirubinemia; intrauterine transfusion; pediatric outcome; Rhesus hemolytic disease

Indexed keywords

RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INFANT; INTRAUTERINE BLOOD TRANSFUSION; MALE; NEWBORN; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHESUS INCOMPATIBILITY; SAMPLE SIZE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 37349123491     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.05.030     Document Type: Article

References (19)

1. van Kamp I.L., Klumper F.J., Meerman R.H., Oepkes D., Scherjon S.A., and Kanhai H.H. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand 83 (2004) 731-737
2. van Kamp I.L., Klumper F.J., Bakkum R.S., et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 185 (2001) 668-673
3. Bowman J.M. The prevention of Rh immunization. Transfus Med Rev 2 (1988) 129-150
4. Jackson J.C. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 99 (1997) E7
5. Ip S., Chung M., Kulig J., et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 114 (2004) e130-e153
6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114 (2004) 297-316
7. Patra K., Storfer-Isser A., Siner B., Moore J., and Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 144 (2004) 626-631
8. Weiner C.P., Williamson R.A., Wenstrom K.D., et al. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment. Am J Obstet Gynecol 165 (1991) 1302-1307
9. Farrant B., Battin M., and Roberts A. Outcome of infants receiving in-utero transfusions for haemolytic disease. N Z Med J 114 (2001) 400-403
10. al Alaiyan S., and al Omran A. Late hyporegenerative anemia in neonates with rhesus hemolytic disease. J Perinat Med 27 (1999) 112-115
11. Millard D.D., Gidding S.S., Socol M.L., et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr 117 (1990) 447-454
12. Oepkes D., van Kamp I.L., Simon M.J., Mesman J., Overbeeke M.A., and Kanhai H.H. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstet Gynecol 184 (2001) 1015-1020
13. Osborn L.M., Lenarsky C., Oakes R.C., and Reiff M.I. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics 74 (1984) 371-374
14. Egberts J., van Kamp I.L., Kanhai H.H., Meerman R.H., Giordano P.C., and Gravenhorst J.B. The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal. BJOG 104 (1997) 818-824
15. Goodrum L.A., Saade G.R., Belfort M.A., Carpenter Jr. R.J., and Moise Jr. K.J. The effect of intrauterine transfusion on fetal bilirubin in red cell alloimmunization. Obstet Gynecol 89 (1997) 57-60
16. Alcock G.S., and Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev (2002) CD003313
17. Trevett Jr. T.N., Dorman K., Lamvu G., and Moise Jr. K.J. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn. Am J Obstet Gynecol 192 (2005) 478-482
18. Thorp J.A., O'Connor T., Callenbach J., et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol 165 (1991) 79-81
19. Ebbesen F. Late anaemia in infants with rhesus haemolytic disease treated with intensive phototherapy. Eur J Pediatr 130 (1979) 285-290